Floatz logo

Valproic Acid

Adverse Effects

Sun Yat-sen UniversitySmall moleculeActive
C
35/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
20/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Adverse Effects cohort.

Asset / SponsorPhaseRating
Bisoprolol Fumarate
Ukrainian Medical Stomatological Academy
Phase 4BB
ISOSORBIDE DINITRATE
Ukrainian Medical Stomatological Academy
Phase 4BB
Rosuvastatin
Ukrainian Medical Stomatological Academy
Phase 4BB
Acetylsalicylic Acid
Ukrainian Medical Stomatological Academy
Phase 4BB
Pioglitazone
Ukrainian Medical Stomatological Academy
Phase 4BB
RAMIPRIL
Ukrainian Medical Stomatological Academy
Phase 4BB
Acalabrutinib
Polish Lymphoma Research Group
Phase 2B
Solu-Cortef
Mahidol University
Phase 2CCC

Same molecule, other indications

Valproic Acid is also rated in:

bipolar I disorderDormant
BBB
Indicative ·
74 / 100
View asset →
epilepsyDormant
BBB
Indicative ·
73 / 100
View asset →
migraine disorderDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →